 Keybank National Association OH reduced its stake in shares of  Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor  owned 1,249,558 shares of the company’s stock after selling 31,995 shares during the period. Procter & Gamble makes up  about  0.7% of Keybank National Association OH’s holdings, making the stock its 24th largest position. Keybank National Association OH owned about 0.05% of Procter & Gamble worth $199,080,000 as of its most recent filing with the SEC.
Keybank National Association OH reduced its stake in shares of  Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor  owned 1,249,558 shares of the company’s stock after selling 31,995 shares during the period. Procter & Gamble makes up  about  0.7% of Keybank National Association OH’s holdings, making the stock its 24th largest position. Keybank National Association OH owned about 0.05% of Procter & Gamble worth $199,080,000 as of its most recent filing with the SEC. 
Several other institutional investors also recently made changes to their positions in the stock. B & T Capital Management DBA Alpha Capital Management boosted its position in shares of Procter & Gamble by 2.3% during the 1st quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock worth $476,000 after purchasing an additional 63 shares in the last quarter. Private Management Group Inc. boosted its position in shares of Procter & Gamble by 4.8% during the 1st quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock worth $236,000 after purchasing an additional 64 shares in the last quarter. Lantz Financial LLC boosted its position in shares of Procter & Gamble by 1.2% during the 2nd quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock worth $834,000 after purchasing an additional 64 shares in the last quarter. Orca Investment Management LLC boosted its position in shares of Procter & Gamble by 2.0% during the 2nd quarter. Orca Investment Management LLC now owns 3,238 shares of the company’s stock worth $516,000 after purchasing an additional 64 shares in the last quarter. Finally, Detalus Advisors LLC boosted its position in shares of Procter & Gamble by 0.8% during the 1st quarter. Detalus Advisors LLC now owns 7,918 shares of the company’s stock worth $1,349,000 after purchasing an additional 65 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Procter & Gamble
In other news, CEO Jon R. Moeller sold 40,119 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares of the company’s stock, valued at $50,228,106.25. This represents a 11.16% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Gary A. Coombe sold 10,194 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares of the company’s stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 149,763 shares of company stock worth $23,421,279. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Trading Down 1.8%
Procter & Gamble (NYSE:PG – Get Free Report) last announced its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The firm had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. During the same quarter in the previous year, the company posted $1.93 EPS. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be paid a $1.0568 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 2.8%. Procter & Gamble’s payout ratio is presently 61.75%.
Analyst Ratings Changes
Several equities research analysts recently commented on the stock. Morgan Stanley set a $175.00 price objective on shares of Procter & Gamble in a research report on Monday. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. JPMorgan Chase & Co. boosted their price objective on shares of Procter & Gamble from $163.00 to $165.00 and gave the stock a “neutral” rating in a research report on Monday. Barclays decreased their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Finally, UBS Group decreased their price objective on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Twelve investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $171.53.
Get Our Latest Stock Report on Procter & Gamble
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- These 3 High-Momentum ETFs Are Riding the Tech Wave
- What is a Stock Market Index and How Do You Use Them?
- Verizon Results Trigger Rebound in High-Yield Stock
- What is Forex and How Does it Work?
- Picks & Shovels: Investing in the Physical Foundation of AI
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						 
						